​

Immunome (IMNM) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChart

Immunome Revenue Highlights

Latest Revenue (Y)

$9.04M

Latest Revenue (Q)

$2.93M

Immunome Revenue by Period

Immunome Revenue by Year

DateRevenueChange
2024-12-31$9.04M-35.50%
2023-12-31$14.02M100.00%
2022-12-31-100.00%
2021-12-31-100.00%
2020-12-31-100.00%
2019-12-31-100.00%
2018-12-31--

Immunome generated $9.04M in revenue during NA 2024, up -35.50% compared to the previous quarter, and up Infinity% compared to the same period a year ago.

Immunome Revenue by Quarter

DateRevenueChange
2025-03-31$2.93M6.87%
2024-12-31$2.74M-5.91%
2024-09-30$2.91M23.10%
2024-06-30$2.36M129.74%
2024-03-31$1.03M-73.11%
2023-12-31$3.83M7.32%
2023-09-30$3.56M-16.37%
2023-06-30$4.26M80.33%
2023-03-31$2.36M100.00%
2022-12-31-100.00%
2022-09-30-100.00%
2022-06-30-100.00%
2022-03-31-100.00%
2021-12-31-100.00%
2021-09-30-100.00%
2021-06-30-100.00%
2021-03-31-100.00%
2020-12-31-100.00%
2020-09-30-100.00%
2020-06-30-100.00%
2020-03-31-100.00%
2019-12-31-100.00%
2019-09-30-100.00%
2019-06-30-100.00%
2019-03-31--

Immunome generated $2.93M in revenue during Q1 2025, up 6.87% compared to the previous quarter, and up 76.48% compared to the same period a year ago.

Immunome Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
CCCCC4 Therapeutics$20.76M$5.18M
IMNMImmunome$9.04M$2.93M
TSHATaysha Gene Therapies$8.33M$1.79M
CUECue Biopharma$5.49M$421.00K
ANEBAnebulo Pharmaceuticals--
ALXOALX Oncology--
FDMT4D Molecular Therapeutics-$1.00K
JBIOJade Biosciences--
CLYMClimb Bio--
ORICORIC Pharmaceuticals--

IMNM Revenue FAQ

What is Immunome’s yearly revenue?

Immunome's yearly revenue for 2024 was $9.04M, representing a decrease of -35.50% compared to 2023. The company's yearly revenue for 2023 was $14.02M, representing an increase of 100.00% compared to 2022. IMNM's yearly revenue for 2022 was $0, representing an increase of 100.00% compared to 2021.

What is Immunome’s quarterly revenue?

Immunome's quarterly revenue for Q1 2025 was $2.93M, a 6.87% increase from the previous quarter (Q4 2024), and a 184.35% increase year-over-year (Q1 2024). The company's quarterly revenue for Q4 2024 was $2.74M, a -5.91% decrease from the previous quarter (Q3 2024), and a -28.44% decrease year-over-year (Q4 2023). IMNM's quarterly revenue for Q3 2024 was $2.91M, a 23.10% increase from the previous quarter (Q2 2024), and a -18.37% decrease year-over-year (Q3 2023).

What is Immunome’s revenue growth rate?

Immunome's revenue growth rate for the last 3 years (2022-2024) was 0%, and for the last 5 years (2020-2024) was 0%.